Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

French techbio company Cure51 has partnered with NVIDIA to accelerate its research into a rare phenomenon: cancer patients who survive against the odds. These outliers, as Cure51 calls them, are the ...